Belgium Luc Van Gorp of the Christian Mutuality Health Insurance Fund, Belgium’s largest health insurance fund, explains the organisation’s role within the Belgian healthcare system, how increased consolidation in recent years has affected its work, the current healthcare paradigm in Belgium, and why inter-stakeholder solidarity is essential to solve the healthcare…
Belgium Glenn Vaughan of the British Chamber of Commerce | EU & Belgium discusses the importance of the Belgium-UK relationship, the role of healthcare and the life sciences within that, and how the Chamber’s work is evolving in the run-up to Brexit. In the field of healthcare and life sciences,…
UAE The Saudi German Hospital Group is one of the leading hospital groups in the Middle East, with hospitals in the UAE, Saudi Arabia, Yemen and Egypt. Dr Reem Osman, CEO for the Group in the UAE, discusses their presence in the country, the Group’s ambitious expansion plans and analyses the…
Morocco CEO Abdelhakim Tahri introduces women’s health player Gynebio Pharma, how the company is disrupting the Moroccan pharmaceutical industry through its range of contraceptive and fertility products, and his vision for regional expansion. Our major focus when creating Gynebio Pharma was creating a company and a production facility that would…
Global Greg Reh leads Deloitte’s global life sciences sector which includes clients in biopharma, medtech, generics and distribution businesses, as well as non-profit patient advocacy organizations and regulatory agencies. He discusses talent acquisition and retention in global life sciences today, the challenges around data and AI uptake, and the future of…
France Speaking exclusively to PharmaBoardroom at the International Women’s Day 2020 event at the Franco-British Chamber of Commerce in Paris, esteemed cardiologist Professor Claire Mounier-Vehier outlines why cardiovascular disease is not simply a masculine issue, the cardio problems particularly affecting women, and why better communication and prevention is vital to countering…
Global With clinical trials having become extremely expensive to conduct, industry buzz around the potential of data and artificial intelligence (AI) to allay these costs has grown. However, experts are split as to the true potential of digital tools to reduce clinical development outlay and provide better patient outcomes in the…
China 2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese government, the entire sector has been virtually turned upside down. Against the warm backdrop of regulatory support, a series of policy changes were unveiled in the…
Global To celebrate International Women’s Day 2020, PharmaBoardroom brings you insights from some of the most inspirational female industry leaders we have had the privilege of talking to over the past 12 months. Janet Woodcock, Director, Center for Drug Evaluation and Research (CDER), US FDA Science really can…
Global In an exclusive and wide-ranging interview, Tom O’Leary, chief information officer (CIO) of leading contract research organisation (CRO), ICON, highlights how data is already revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes. O’Leary also…
Romania László Attila, president of the Committee of Public Health of Romania, highlights the Committee’s efforts to mitigate the detrimental effects of Romania’s looming demographic crisis and medical “brain-drain”. Furthermore, he evaluates the country’s success in increasing the healthcare budget and emphasizes the importance of stable legislation. Romania has the…
Belgium Frank Swaelens, general manager of IQVIA in Belgium and Luxembourg, offers insights into the healthcare and life science ecosystem of Belgium and highlights the opportunities that exist for the country in innovation and digitalization. Swaelens goes on to describe the collaborative role that IQVIA can play as a human data…
See our Cookie Privacy Policy Here